Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a publicly traded Healthcare sector company. As of October 3, 2026, AMRX trades at $20.45 with a market cap of $7.07B and a P/E ratio of 88.91. AMRX moved +1.15% today. Year to date, AMRX is +60.35%; over the trailing twelve months it is +95.19%. Its 52-week range spans $6.69 to $21.18. Analyst consensus is strong buy with an average price target of $21.20. Rallies surfaces AMRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AMRX moved +1.15% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $20.45 |
| Market Cap | $7.07B |
| P/E Ratio | 88.91 |
| EPS | $0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.18 |
| 52-Week Low | $6.69 |
| Volume | 1.84M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.02B |
| Net Income | $127.93M |
| Gross Margin | 36.88% |
6 analysts cover AMRX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.20.